ArticleJournal of cellular and molecular medicine2021

Novel chimeric TLR2/NOD2 agonist CL429 exhibited significant radioprotective effects in mice.

Ying Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.